327 related articles for article (PubMed ID: 18980970)
1. Reciprocal CD4+ T-cell balance of effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ regulatory T cells in small cell lung cancer reflects disease stage.
Koyama K; Kagamu H; Miura S; Hiura T; Miyabayashi T; Itoh R; Kuriyama H; Tanaka H; Tanaka J; Yoshizawa H; Nakata K; Gejyo F
Clin Cancer Res; 2008 Nov; 14(21):6770-9. PubMed ID: 18980970
[TBL] [Abstract][Full Text] [Related]
2. Foxp3 expressing CD4+ CD25+ and CD8+CD28- T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma.
Meloni F; Morosini M; Solari N; Passadore I; Nascimbene C; Novo M; Ferrari M; Cosentino M; Marino F; Pozzi E; Fietta AM
Hum Immunol; 2006; 67(1-2):1-12. PubMed ID: 16698419
[TBL] [Abstract][Full Text] [Related]
3. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.
Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P
J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277
[TBL] [Abstract][Full Text] [Related]
5. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.
Sasada T; Kimura M; Yoshida Y; Kanai M; Takabayashi A
Cancer; 2003 Sep; 98(5):1089-99. PubMed ID: 12942579
[TBL] [Abstract][Full Text] [Related]
6. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
7. Children with egg allergy have evidence of reduced neonatal CD4(+)CD25(+)CD127(lo/-) regulatory T cell function.
Smith M; Tourigny MR; Noakes P; Thornton CA; Tulic MK; Prescott SL
J Allergy Clin Immunol; 2008 Jun; 121(6):1460-6, 1466.e1-7. PubMed ID: 18455222
[TBL] [Abstract][Full Text] [Related]
8. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy in patients with ankylosing spondylitis: do regulatory T cells play a role?
Förger F; Villiger PM; Ostensen M
Arthritis Rheum; 2009 Feb; 61(2):279-83. PubMed ID: 19177540
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T
Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation.
Sewgobind VD; van der Laan LJ; Klepper M; Ijzermans JN; Tilanus HW; Weimar W; Baan CC
Clin Transplant; 2008; 22(5):579-86. PubMed ID: 18435785
[TBL] [Abstract][Full Text] [Related]
13. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
14. Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy.
Zhang L; Dermawan K; Jin M; Liu R; Zheng H; Xu L; Zhang Y; Cai Y; Chu Y; Xiong S
Clin Immunol; 2008 Nov; 129(2):219-29. PubMed ID: 18771959
[TBL] [Abstract][Full Text] [Related]
15. Increase of regulatory T cells in the peripheral blood of cancer patients.
Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B
Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425
[TBL] [Abstract][Full Text] [Related]
16. GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells.
Igarashi H; Cao Y; Iwai H; Piao J; Kamimura Y; Hashiguchi M; Amagasa T; Azuma M
Biochem Biophys Res Commun; 2008 May; 369(4):1134-8. PubMed ID: 18346459
[TBL] [Abstract][Full Text] [Related]
17. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.
Tsurikisawa N; Saito H; Tsuburai T; Oshikata C; Ono E; Mitomi H; Akiyama K
J Allergy Clin Immunol; 2008 Sep; 122(3):610-6. PubMed ID: 18586318
[TBL] [Abstract][Full Text] [Related]
18. Micro-inflammation characterized by disturbed Treg/Teff balance with increasing sIL-2R in patients with type 2 diabetes.
Cai B; Zhang J; Zhang M; Li L; Feng W; An Z; Wang L
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):214-9. PubMed ID: 23595796
[TBL] [Abstract][Full Text] [Related]
19. The role of oxidized low-density lipoprotein in breaking peripheral Th17/Treg balance in patients with acute coronary syndrome.
Li Q; Wang Y; Chen K; Zhou Q; Wei W; Wang Y; Wang Y
Biochem Biophys Res Commun; 2010 Apr; 394(3):836-42. PubMed ID: 20302843
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer.
Masuno T; Ikeda T; Yokota S; Komuta K; Ogura T; Kishimoto S
Cancer Res; 1986 Aug; 46(8):4195-9. PubMed ID: 3015385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
